CATX · Perspective Therapeutics, Inc. · Documents
$2.57
-0.19 (-6.88%)
At close · Oct 5
Return incl. dividend (before tax)
Market Cap
$299.08M
Shares
114.15M
Volume · Oct 5
3.56M
Avg daily vol (3M)
1.66M
The company's filings as submitted to the SEC's EDGAR system — 10-K, 10-Q, 8-K, proxy statements and more — listed most recent first.
| Type | Filing Date | Period | Open |
|---|---|---|---|
| 8-K | 2026-10-01 | — | |
| Investor Event Transcript | 2026-09-16 | 2026-09-30 | |
| Investor Event Transcript | 2026-09-16 | 2026-09-30 | |
| 8-K | 2026-09-14 | — | |
| 8-K | 2026-09-08 | — | |
| 8-K | 2026-08-10 | — | |
| 10-Q | 2026-08-10 | 2026-06-30 | |
| 8-K | 2026-08-03 | — | |
| 8-K | 2026-07-01 | — | |
| 8-K | 2026-06-01 | — | |
| 8-K | 2026-05-27 | — | |
| 8-K | 2026-05-22 | 2026-05-21 | |
| 8-K | 2026-05-11 | — | |
| 10-Q | 2026-05-11 | 2026-03-31 | |
| 8-K | 2026-05-04 | — | |
| 8-K | 2026-04-20 | 2026-04-18 | |
| DEF 14A | 2026-04-16 | 2026-04-15 | |
| 8-K | 2026-04-01 | — | |
| 8-K | 2026-03-16 | — | |
| 10-K | 2026-03-16 | 2025-12-31 | |
| 8-K | 2026-02-03 | 2026-02-02 | |
| 8-K | 2026-02-02 | — | |
| 8-K | 2026-01-14 | — | |
| 8-K | 2026-01-12 | — | |
| 8-K | 2026-01-09 | — | |
| 8-K | 2025-12-01 | — | |
| 10-Q | 2025-11-10 | 2025-09-30 | |
| 8-K | 2025-11-10 | — | |
| 8-K | 2025-11-06 | — | |
| 8-K | 2025-11-03 | — | |
| 8-K | 2025-10-20 | — | |
| 8-K | 2025-10-01 | — | |
| 8-K | 2025-09-04 | 2025-09-02 | |
| 8-K | 2025-09-03 | 2025-09-02 | |
| 8-K | 2025-09-02 | — | |
| 10-Q | 2025-08-13 | 2025-06-30 | |
| 8-K | 2025-08-13 | — | |
| 8-K | 2025-08-01 | — | |
| 8-K | 2025-07-03 | — | |
| 8-K | 2025-06-23 | 2025-06-21 | |
| 8-K | 2025-06-03 | — | |
| 8-K | 2025-05-30 | — | |
| 8-K | 2025-05-28 | — | |
| 8-K | 2025-05-12 | — | |
| 10-Q | 2025-05-12 | 2025-03-31 | |
| 8-K | 2025-05-01 | — | |
| 8-K | 2025-04-29 | — | |
| DEF 14A | 2025-04-16 | 2024-12-31 | |
| 8-K | 2025-04-11 | — | |
| 10-K/A | 2025-03-28 | 2024-12-31 |
Showing 1–50 of 179 filings